title: Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate.
abstract: OBJECTIVE
  To determine the effects of the thermolabile methylene tetrahydrofolate reductase (MTHFR) mutation on the presence and extent of coronary atherosclerosis in a population with low plasma folate.
  
  
  METHODS
  242 consecutive patients undergoing coronary angiography were prospectively evaluated for conventional risk factors, plasma homocysteine, vitamin B-12, and folate, and MTHFR genotype. The severity of coronary atherosclerosis was determined by the Leaman score.
  
  
  RESULTS
  Mean (SD) plasma homocysteine was 15.6 (10) micromol/l in controls and 18.5 (11) micromol/l in patients with coronary artery disease (p > 0.05). Plasma homocysteine concentrations above 15 micromol/l were a risk factor for coronary artery disease (p = 0.03, risk ratio 2.1, 95% confidence interval (CI) 1.07 to 4.4). Homocysteine remained an independent risk factor on multivariate analysis when conventional risk factors were taken into account (p = 0.04). Homocysteine concentrations above 15 micromol/l were correlated with the extent of atherosclerosis (p = 0. 04, risk ratio 3.2, 95% CI 1.3 to 8.2). Homocysteine had no effect on other lipid variables (p > 0.05). Plasma folate was 15.8 (7.2) nmol/l in controls and 11.5 (2.9) nmol/l in patients with coronary artery disease. Plasma folate concentrations below 12.9 nmol/l (5.7 ng/ml) conferred a risk for coronary artery disease (p = 0.03, risk ratio 2.42, 95% CI 1.05 to 5.59). When the MTHFR genotype was determined, the TT genotype was present in 7.4% of patients and 5.2% of controls (p > 0.05). The prevalence of alleles was within the Hardy-Weinberg equilibrium (TT 7, CT 40, CC 53, chi2 = 2.3, p = 0.3). The highest homocysteine concentrations were found in patients with the TT genotype and folate below the median of the population (p = 0. 01). The extent of coronary atherosclerosis judged by the Leaman score was significantly higher in patients with the TT genotype (p = 0.03).
  
  
  CONCLUSIONS
  Plasma homocysteine over 15 micromol/l was a significant risk factor for the presence and extent of coronary artery disease. The mean plasma folate of the population was low and correlated negatively with homocysteine. Although TT genotype was not an independent predictor of coronary artery disease, it was an important predictor of the extent of coronary atherosclerosis and plasma homocysteine, especially in the presence of plasma folate values below the median of the population. These findings may have important implications for folate replacement in patients with the TT genotype.
authors.affiliation: Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara 06100, Turkey.
authors.forename: S L
authors.initials: SL
authors.lastname: Tokgözoğlu
authors.forename: M
authors.initials: M
authors.lastname: Alikaşifoğlu
authors.lastname: Unsal
authors.forename: E
authors.initials: E
authors.lastname: Atalar
authors.forename: K
authors.initials: K
authors.lastname: Aytemir
authors.forename: N
authors.initials: N
authors.lastname: Ozer
authors.forename: K
authors.initials: K
authors.lastname: Ovünç
authors.forename: O
authors.initials: O
authors.lastname: Usal
authors.forename: S
authors.initials: S
authors.lastname: Kes
authors.forename: E
authors.initials: E
authors.lastname: Tunçbilek
mesh_terms: D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000235:genetics*; D005492:Folic Acid / Q000097:blood*; D005838:Genotype; D006710:Homocysteine / Q000097:blood; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP) / Q000235:genetics*; D016017:Odds Ratio; D016133:Polymerase Chain Reaction; D012044:Regression Analysis; D012306:Risk; D014421:Turkey; D014805:Vitamin B 12 / Q000097:blood
chemical_list: D008075:Lipoproteins, HDL; D006710:Homocysteine; D005492:Folic Acid; D002784:Cholesterol; D008754:Methylenetetrahydrofolate Dehydrogenase (NADP); D014805:Vitamin B 12